Company Overview of SynGlyco, Inc.
SynGlyco, Inc. develops novel vaccines using synthetic carbohydrates. It offers immune system modulation therapeutics. SynGlyco, Inc. was formerly known as Ancora Pharmaceuticals, Inc. and changed its name to SynGlyco, Inc. in November 2013. The company was incorporated in 2001 and is based in Medford, Massachusetts.
200 Boston Avenue
Medford, MA 02155
Founded in 2001
Key Executives for SynGlyco, Inc.
Similar Private Companies By Industry
|Mist Pharmaceuticals, LLC||United States|
|Epic Pharma, L.L.C||United States|
|Foundation Consumer Healthcare, LLC||United States|
|Shire Regenerative Medicine, Inc.||United States|
|Targeted Cell Therapies LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact SynGlyco, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.